GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Total Equity

TDS Pharm Co (XKRX:464280) Total Equity : ₩22,945 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Total Equity?

TDS Pharm Co's total equity for the quarter that ended in Dec. 2023 was ₩22,945 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

TDS Pharm Co Total Equity Historical Data

The historical data trend for TDS Pharm Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Total Equity Chart

TDS Pharm Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Equity
16,338.92 16,142.85 18,308.46 22,944.54

TDS Pharm Co Quarterly Data
Dec20 Dec21 Dec22 Dec23
Total Equity 16,338.92 16,142.85 18,308.46 22,944.54

TDS Pharm Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

TDS Pharm Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=33970.008-11025.465
=22,945

TDS Pharm Co's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=33970.008-11025.465
=22,945

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TDS Pharm Co Total Equity Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Total Equity
Comparable Companies
XKRX:004720 XKRX:014570 XKRX:118000 XKRX:200780 XKRX:307750 LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN GILD BMY TSE:4519 LSE:GSK
Traded in Other Exchanges
N/A
Address
253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
Website
https://www.tdspharm.com
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines